In 2015, Saunders and coworkers reported the results of an interesting study showing a high expression of the NOTCH inhibitory ligand Delta-like 3 (DLL3) in SCLC cell lines and primary tumors [104]. This evidence concerns the gene DLL3 and small cell lung carcinoma.